Bodil O. Hansen
and Hans keiding
Bodil O. Hansen: Department of Economics, Copenhagen Business School, Postal: Department of Economics, Copenhagen Business School, Solbjerg Plads 3 C, 5. sal, DK-2000 Frederiksberg, Denmark
Hans keiding: University of Copenhagen, Postal: University of Copenhagen, Institute of Public Health Research,, Blegdamsvej 5,, DK-2200 Copenhagen K.
Abstract: In this paper, the reimbursement of spending on medicin is considered as a problem of insurance, where the loss due to illness of the insured is covered totally or partially by an insurance company (which may be the government). The presence of moral hazard (in the form of the individual patient’s own effort to reduce cost by avoiding unnecessary medicination and choosing the cheapest drugs) implies that an optimal insurance will have less than total coverage of the patient outlays. The insurance approach to drug subsidization indicates that reimburse-ment should vary with the type of medicin rather than with accumulated pa-tient outlays. Also, secondary investment covering the remaining part of the patient’s outlays, a feature of the reimbursement system in some countries, is suboptimal.
13 pages, November 1, 1999
Full text files
Questions (including download problems) about the papers in this series should be directed to Lars Nondal ()
Report other problems with accessing this service to Sune Karlsson ().
This page generated on 2018-01-23 23:31:11.